Edward Tsai

Edward actively supports Namier healthcare vertical with strategic advice and consulting. He has extensive networks with academic medical centers, biotechnology, pharmaceutical, life science, and technology companies. Edward is particularly experienced in topics such as medical devices, digital health, oncology, and cell therapy.

• 15 years of experience across all sectors of healthcare including life sciences, biotechnology, diagnostics, academic medicine, and digital / technology
• Former PwC strategy consultant focused on precision medicine, genetic sequencing, and rare disease / cancer diagnostics and therapeutics
• Experienced with developing and executing strategies at startups to Fortune 500 companies in highly innovative and disruptive areas of healthcare such as chimeric antigen receptor T-cell (CAR-T) therapy, AI / ML / digital, and liquid biopsy